Gain Therapeutics Inc. (GANX)
2.13
0.05 (2.40%)
At close: Jan 15, 2025, 3:59 PM
2.13
0.00%
After-hours Jan 15, 2025, 04:09 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -1.91 | -2.11 | -3.97 | -37.18 | -60.64 | -59.37 |
| PS Ratio | 771.06 | 265.47 | 334.55 | 4.61K | 3.22K | 3.18K |
| PB Ratio | 3.38 | 1.97 | 1.59 | 21.45 | -295.69 | -69.02 |
| P/FCF Ratio | -2.25 | -2.51 | -4.43 | -40.79 | -70.67 | -87.22 |
| P/OCF Ratio | -2.26 | -2.53 | -4.46 | -41.05 | -71.19 | -88.16 |
| OCF/S Ratio | -341.9 | -104.86 | -74.95 | -112.19 | -45.24 | -36.13 |
| Debt / Equity Ratio | 0.08 | 0.07 | 0.05 | 0.20 | -0.45 | -1.27 |
| Quick Ratio | 3.59 | 5.11 | 14.78 | 3.61 | 0.45 | 0.93 |
| Current Ratio | 3.59 | 5.11 | 14.78 | 4.25 | 0.49 | 0.93 |
| Asset Turnover | 0.00 | 0.01 | 0.00 | 0.00 | 0.06 | 0.03 |
| Interest Coverage | n/a | n/a | n/a | n/a | -102.24 | n/a |
| Return on Equity (ROE) | -1.77 | -0.93 | -0.4 | -0.58 | 4.88 | 1.16 |
| Return on Assets (ROA) | -1.2 | -0.73 | -0.36 | -0.37 | -3.32 | -1.36 |
| Return on Capital (ROIC) | -1.63 | -0.89 | -0.38 | -0.46 | 9.60 | -3.66 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -45.67% | 54.20% | -4.24K% | -7.72K% | 100.00% | 100.00% |
| Net Profit Margin | -40.35K% | -12.56K% | -8.42K% | -12.39K% | -5.31K% | -5.36K% |
| Pretax Profit Margin | -40.21K% | -12.49K% | -8.42K% | -12.37K% | -5.29K% | -5.32K% |
| Operating Profit Margin | -40.33K% | -12.69K% | -8.38K% | -12.05K% | -5.08K% | -4.99K% |
| FCF Margin | -34.22K% | -10.57K% | -7.55K% | -11.29K% | -4.56K% | -3.65K% |
| EBITDA Margin | -40.18K% | -12.69K% | -8.38K% | -12.01K% | -5.08K% | -4.99K% |